Paul Scigalla

Chief Tech/Sci/R&D Officer at GENELUX CORPORATION

79 year

Health Technology

Consumer Services

Finance

Profile

Paul Scigalla is currently the Chief Medical Officer at Genelux Corp.
since 2011 and a Professor at Ruprecht-Karls-Universität Heidelberg since 1992.
He was previously the Executive Vice President at Sugen, Inc. from 1998 to 2001.
He also held the position of Chief Medical Officer at Nuevolution AB and Deutsche Biotech Innovativ AG.
Scigalla obtained his doctorate degree from Humboldt-Universität zu Berlin.

Paul Scigalla active positions

Companies	Position	Start
GENELUX CORPORATION	Chief Tech/Sci/R&D Officer	2011-08-31
Ruprecht-Karls-Universität Heidelberg	Corporate Officer/Principal	1991-12-31

All active positions of Paul Scigalla

Former positions of Paul Scigalla

Companies	Position	End
Sugen, Inc. Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY.	Corporate Officer/Principal	2000-12-31
NUEVOLUTION AB (PUBL)	Chief Tech/Sci/R&D Officer	-
DEUTSCHE BIOTECH INNOVATIV AG	Chief Tech/Sci/R&D Officer	-

See the detail of Paul Scigalla's experience

Training of Paul Scigalla

Humboldt-Universität zu Berlin

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Scigalla's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
DEUTSCHE BIOTECH INNOVATIV AG	Finance
GENELUX CORPORATION	Health Technology

Private companies	2
Nuevolution AB Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark.	Health Technology
Sugen, Inc. Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY.	Health Technology